Cheapest GLP-1 With Insurance in 2026: The Real Lowest-Cost Paths

Last verified: April 21, 2026 · Written and fact-checked by the Weight Loss Provider Guide research team

Affiliate disclosure: We may earn commissions from Ro and Sesame Care. Our picks are based on verified pricing, coverage fit, and FDA-approved status — not payout.

Cheapest GLP-1 with insurance — 4-step coverage path guide: step 1 check coverage and verify in-network prescriber, step 2 use your prescriber to get the script and prior authorization, step 3 choose a covered FDA-approved GLP-1 option at pharmacy, step 4 compare next steps if denied (appeal, switch drug, or cash-pay fallback)

The cheapest GLP-1 with insurance is a path, not a product. Verified against FDA, CMS, and manufacturer sources, April 21, 2026.

Here’s the part nobody explains clearly: five FDA-approved GLP-1s can cost as little as $25/month with insurance — Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo. (A sixth, Rybelsus, also has a $25 path if you have type 2 diabetes and commercial coverage.) The cheapest GLP-1 with insurance isn’t a single drug. It’s a path. Which drug your plan actually covers, whether you stack the manufacturer savings card on top, and — the part most “cheapest” pages bury or skip — whether you already have an in-network doctor willing to write the script.

If you do, that’s your cheapest path. You don’t need us. You don’t need any telehealth membership. Your drug can drop as low as $25 per fill, your only extra cost is whatever your plan asks for at the office (copay, deductible, or coinsurance), and you can close this tab.

If you don’t — or your insurance is already dragging you through prior authorization hell — we’ll show you exactly where to go next. Everything below is the real breakdown: the verified cost stack for every FDA-approved GLP-1, the Zepbound annual savings cap that mid-year blows up the $25 number nobody else mentions, the three legitimate paths forward if your insurance says no, and exactly what changes on July 1, 2026 when Medicare’s GLP-1 Bridge goes live.

✅ What we actually verified for this page (April 21, 2026):

  • • Wegovy, Ozempic, Rybelsus savings card terms pulled directly from NovoCare.
  • • Zepbound, Mounjaro, Foundayo savings card terms from Lilly’s official savings pages and Foundayo.lilly.com/coverage-savings.
  • • 2026 monthly and annual savings caps confirmed against manufacturer terms and conditions.
  • • Medicare GLP-1 Bridge eligibility criteria confirmed from CMS.gov (page updated April 6, 2026).
  • • Ro Body membership pricing and Insurance Coverage Checker mechanics confirmed at ro.co/weight-loss/pricing.
  • • Medicaid obesity-coverage count (13 states) from the Kaiser Family Foundation’s January 2026 Medicaid GLP-1 tracker.
  • • Employer coverage rates from Peterson-KFF Health System Tracker (2025 data).

The 30-Second Answer: What Is the Cheapest GLP-1 With Insurance?

The cheapest GLP-1 with insurance is an FDA-approved brand-name drug your plan already covers, stacked with the manufacturer’s savings card. For eligible commercially insured patients, that brings Wegovy, Zepbound (KwikPen), Ozempic, Mounjaro, or Foundayo to as little as $25/month. The winner depends on which of those five (or Rybelsus, if you have type 2 diabetes) is on your specific plan’s formulary — not which drug has the lowest list price.

“Cheapest GLP-1 with insurance” has one honest answer and three conditions that can change it:

1
You have commercial insurance: An employer plan, marketplace plan, or individual private plan. Medicare, Medicaid, TRICARE, VA, and DoD beneficiaries are excluded from every manufacturer savings card program by federal law. That's a separate path (Medicare GLP-1 Bridge), covered below.
2
Your plan covers the drug: Per Ro's 2025 GLP-1 Insurance Coverage Checker Report, 43% of people who ran a coverage check had coverage for a GLP-1 for weight loss, while nearly all had coverage for a GLP-1 for type 2 diabetes. If you have T2D, Ozempic or Mounjaro are usually the fastest route to $25.
3
You stack the savings card: The card is free, takes about three minutes to activate online, and runs automatically at the pharmacy counter after your insurance processes. Without it, you pay whatever your plan's specialty-tier copay or coinsurance is — often $100 to $400/month.
Hit all three, you land around $25. Miss one, and the number jumps. The rest of this page walks every branch.
Check which GLP-1s your plan covers — free

Ro’s free Insurance Coverage Checker contacts your insurer on your behalf and sends you a personalized report covering your estimated copay and prior-authorization status per drug. No commitment required.

The Real Cost Ladder: Six Paths Compared by Route

Most “cheapest GLP-1” pages compare drug prices. That’s half the story. The total cost of getting a GLP-1 through insurance is the drug cost plus the extra fee layer — office copay, membership fee, visit fee, deductible, coinsurance, or prior-auth friction. This is where most pages lie to you by omission.

Six paths to a GLP-1 with insurance, by total cost stack. Verified against provider pricing pages, April 21, 2026. Drug cost floor assumes commercial insurance coverage + savings card.
PathDrug Cost Floor
1. Your in-network doctor$25/mo (savings card, if plan covers)
2. Ro (free coverage check + optional Body membership)$25/mo if covered; $149–$449/mo cash pay if not
3. Form Health$25/mo if covered; $299/mo program fee if not covered
4. WeightWatchers Med+$25/mo if covered (via savings card)
5. PlushCare$25/mo if covered
6. Sesame Care$25/mo if covered

Primary sources: NovoCare, Zepbound Savings, Foundayo Savings, Ro Pricing

The honest read of this table

If you already have an in-network doctor and your insurance covers a GLP-1, Path 1 is almost always the cheapest path in the U.S. An affiliate telehealth membership — including the ones on this page we earn a commission from — cannot beat “your existing doctor writes the script and your insurance does its job.” We’d rather tell you that and lose the click than pretend otherwise.

If your plan covers the drug and covers clinical visits and labs, Form Health’s insurance-billed model can be the cheapest telehealth route, because the bulk of what you pay is your normal cost-sharing. Form Health is not one of our affiliate partners — we’re including it because this page’s job is to show you the truth.

For most people without an existing prescriber or without confirmed plan coverage, Ro’s free coverage check is our honest first move. And here’s the damaging admission most affiliate pages hide: Ro does not have the cheapest membership on this list. PlushCare ($19.99/mo) and WeightWatchers Med+ ($74/mo ongoing after intro) both undercut Ro on monthly fee. If membership fee alone is your priority, go look at those.

But because Ro’s Insurance Coverage Checker is genuinely free to run, and because Ro’s insurance concierge files prior authorization paperwork for you if you do join, it’s the lowest-risk, highest-certainty first action for a commercial-insurance shopper who doesn’t already have a doctor handling this. You can check what your plan covers without committing to Ro’s $149/month membership — then decide where you actually want to go next.

How Much Does Each GLP-1 Actually Cost With Insurance in 2026?

With commercial insurance plus the manufacturer savings card, five FDA-approved GLP-1s hit a $25/month floor. Without that stack — or with government insurance — the numbers are very different. Below is the verified 2026 cost of every major FDA-approved GLP-1, including the caps and catches most pages skip.

Patient and doctor reviewing insurance coverage options on a tablet — start with coverage clarity: the lowest-cost GLP-1 path usually begins with what your plan already covers
Check your coverage free

Start with coverage clarity. Click to check which GLP-1s your plan covers — free, via Ro’s Insurance Coverage Checker. (Affiliate link.)

Wegovy (semaglutide)

Novo Nordisk · Weight loss, cardiovascular risk reduction, MASH

$25/mo
With commercial coverage + savings card: As low as $25/month (max savings $100/month per 1-month supply)
Without coverage (cash-pay): $349/month ongoing; first 2 starter-dose fills $199/month for new patients through June 30, 2026
Pill/tablet option: Wegovy pill starter doses $149/month self-pay through Aug 31, 2026; maintenance 9mg/25mg $299/month
Medicare path: $50/month via Medicare GLP-1 Bridge (July 1 – Dec 31, 2026) — all formulations included
Government beneficiaries excluded from savings card by federal law (Medicare, Medicaid, TRICARE, VA, DoD, Medigap)

Source: NovoCare Wegovy Savings

Zepbound (tirzepatide)

Eli Lilly · Weight loss, obstructive sleep apnea

$25/mo
With commercial coverage + savings card: As low as $25/month
Without coverage (cash-pay): $299/month for 2.5mg; $399 for 5mg; $449 for 7.5mg–15mg (Journey Program)
Pill/tablet option: Injection only (KwikPen)
Medicare path: $50/month via Bridge (July 1 – Dec 31, 2026) — KwikPen only; single-dose vials/pens NOT included
⚠️ Annual savings cap: $1,300 per calendar year. If your plan's copay is high, you can hit this cap around month 7–8 and pay full copay until Jan 1. Card expires 12/31/2026.

Source: Zepbound Savings Options

Ozempic (semaglutide)

Novo Nordisk · Type 2 diabetes; cardiovascular risk reduction in diabetic adults

$25/mo
With commercial coverage + savings card: As little as $25/month (max savings $100/month; up to 48 months from activation)
Without coverage (cash-pay): $349/month for 0.25–1mg; $499/month for 2mg. First 2 fills $199/month for new patients through June 30, 2026
Medicare path: Medicare Part D typically covers for T2D — standard plan PA applies (no Bridge needed for T2D)
Approved for T2D only. Off-label weight-loss prescribing gets denied far more often. If you have T2D, this is usually the fastest path to $25.

Source: Ozempic Savings

Mounjaro (tirzepatide)

Eli Lilly · Type 2 diabetes

$25/mo
With commercial coverage + savings card: As little as $25/month (max savings $150/month; annual cap $1,950)
Without coverage (cash-pay): As low as $499/month with savings card (no plan coverage). List price ~$1,080–$1,300/month without any card.
Medicare path: Medicare Part D typically covers for T2D — standard plan PA applies
Annual savings cap: $1,950. Card expires 12/31/2026. Lilly's self-pay programs are focused on Zepbound for weight-loss patients.

Source: Lilly Mounjaro Savings & Support

Foundayo (orforglipron)

Eli Lilly · Weight loss (FDA-approved April 2026, oral GLP-1 pill)

$25/mo
With commercial coverage + savings card: As low as $25/month (max savings $100/month; up to 10 fills per calendar year)
Without coverage (cash-pay): $149/month for 0.8mg starter; $199/month for 2.5mg; $299/month for 5.5mg–17.2mg (Journey Program at $349 if not refilling within 45 days)
Format advantage: Once-daily oral tablet — no food-timing restrictions (advantage over Wegovy pill)
Medicare path: $50/month via Bridge (July 1 – Dec 31, 2026) — added to Bridge drug list April 6, 2026
Card allows up to 10 fills per calendar year. Card expires 12/31/2026. Cheapest FDA-approved fallback if coverage denied: $149/month starter dose.

Source: Foundayo Coverage & Savings

Rybelsus (oral semaglutide)

Novo Nordisk · Type 2 diabetes

$25/mo
With commercial coverage + savings card: As low as $25/month for eligible T2D patients (max savings $150/month)
Without coverage (cash-pay): List price ~$1,010/month. Few direct-to-consumer cash-pay programs.
Format: Oral tablet (this is the oral formulation)
Medicare path: Medicare Part D typically covers for T2D — standard plan PA applies
Strong option for T2D patients — easier prior auth than obesity-indicated drugs. For weight-loss-only patients, this is not the right path.

Source: NovoCare Rybelsus

Saxenda (liraglutide — daily injection for weight loss)

Included for completeness: Novo ended the Saxenda savings program years ago, so there’s no active $25 path. If your plan covers it, you pay your plan’s standard specialty copay. In 2026, most patients will land on Wegovy, Zepbound, or Foundayo as better answers.

The cross-drug truth: Five drugs have identical $25 floors — that’s not a coincidence, it’s what the manufacturer savings programs were designed to do. The real question isn’t “which drug is cheapest” — it’s “which drug does my plan cover, will the PA go through, and will I hit the annual savings cap mid-year?” That’s what the free coverage check resolves in minutes instead of hours on hold.

So Which Route Is Cheapest for You Specifically?

If you already have an in-network PCP or endocrinologist

You have the cheapest path available. Use it.

Ask your doctor at your next visit whether they’ll prescribe Wegovy, Zepbound, or Foundayo (for weight loss) or Ozempic, Mounjaro, or Rybelsus (for type 2 diabetes). If they’ll write a script for one your plan covers, your drug cost can land at $25 and your only additional cost is whatever your plan asks for at the office. You don’t need any telehealth platform.

Two things to bring to the appointment to speed up approval:

  1. Your insurance card plus a quick coverage check (call the number on the back and ask: “Do you cover [drug name] for [indication]? Is prior authorization required? What’s the formulary tier?”).
  2. Weight history, BMI documentation, and notes on any comorbidities — high blood pressure, high cholesterol, sleep apnea, prediabetes — that strengthen the prior auth.
No affiliate, no membership. If this is your cheapest path, take it. Use the Prior Authorization Checklist in the section below — print it and bring it to your appointment.

If you don’t have a doctor or your PA is already stuck

Your cheapest move is running Ro’s free coverage check first, then deciding whether to join Ro Body for the prescriber + insurance concierge.

The practical flow:

  1. Run Ro’s free GLP-1 Insurance Coverage Checker — it’s free. Enter your insurance info, Ro contacts your insurer, and you receive a personalized report showing which GLP-1s your plan covers, whether PA is required, and your estimated copay per drug.
  2. If your plan covers a GLP-1 and you want Ro to handle prescribing and PA: join Ro Body at $39 first month, then $149/month (or as low as $74/month with annual prepay). Ro’s insurance concierge files the PA paperwork on your behalf. Ro reports that commercial insurance setup typically takes 1–3 weeks from signup to first fill.
  3. If your plan denies coverage but you still want FDA-approved brand medication, Ro offers Wegovy pill at $149/month first then $199–$299, Wegovy pen at $199/month first then $199–$349, Zepbound KwikPen at $299/month first then $399–$449, and Foundayo at $149/month first then $199–$299 — all matching LillyDirect and NovoCare Pharmacy pricing.

If you want the lowest membership fee (and you’re willing to commit)

Consider WeightWatchers Med+ (free cost estimator, $25/month intro for 2 months then $74/month on a 12-month plan) or PlushCare ($19.99/month membership plus per-visit copays). Both accept insurance and your drug cost can land at the same $25 floor if your plan covers the drug. Neither is our direct affiliate partner — we’re including them because the honest cheapest answer matters more than our commission.

If you want an obesity-specialist program billed through insurance

Form Health is worth a look. Form Health is a telehealth obesity care provider that bills clinician visits, lab tests, and medications through most major private insurance and Medicare (you pay your plan’s cost-sharing). Self-pay is $299/month if your plan doesn’t cover their program. Form Health is not one of our affiliate partners — we’re including it because on an insurance-first query, leaving it out would be dishonest.

If you have Medicare or Medicaid

Different rules entirely — manufacturer savings cards are excluded for government beneficiaries by federal law. Your path is the Medicare GLP-1 Bridge (launching July 1, 2026) or your state’s Medicaid formulary. See the Medicare/Medicaid section below.

If your insurance already denied you

See the “What If Your Insurance Says No?” section below for the three paths forward.

How the $25/Month Floor Actually Works (And When It Breaks)

The $25 number is two discounts stacked on top of each other. Your commercial insurance pays the bulk of the drug’s list price. The manufacturer’s savings card covers most of what’s left. If your plan’s copay is $100 or less, the card brings you to $25. If your plan’s copay is $400, the card can’t close the full gap — you’ll land somewhere around $300.

Layer 1: Your insurance

A GLP-1’s list price is typically $1,000–$1,800/month. Your plan pays the bulk of that. You’re left owing a copay, coinsurance, or deductible depending on your plan’s specialty tier.

Layer 2: The savings card

The card pays down most of your remaining out-of-pocket cost, capped at $100/month for Wegovy, Zepbound, Ozempic, Foundayo, and Rybelsus, or $150/month for Mounjaro. If your copay is already under $25, the card doesn’t help.

The four scenarios where $25 breaks

1
Government insurance: Medicare, Medicaid, TRICARE, VA, DoD, Medigap. Federal law prohibits manufacturer copay cards on government plans. The Medicare GLP-1 Bridge launching July 1, 2026 is the separate path for Medicare beneficiaries.
2
Plan excludes the drug entirely: The card still helps — you'll get the manufacturer's cash-pay floor (usually $149–$499/month depending on drug) instead of retail — but you won't hit $25.
3
You hit the annual savings cap: Zepbound's cap is $1,300 per calendar year. Mounjaro's cap is $1,950. If your plan's copay is high enough that the card is covering close to the monthly max, you can run out several months before year-end and pay your plan's full copay until January 1.
4
Your copay is already below $25: Some generous plans put Wegovy or Zepbound on a preferred tier with a $10–$15 copay. You're already beating the floor; the card is irrelevant.

Activation — three minutes, one time

  1. Confirm you have commercial (not government) insurance.
  2. Go to the manufacturer’s savings page:
  3. Enter your info, get the digital card, add it to Apple or Google Wallet.
  4. Hand it to the pharmacist with your prescription. They run it as a secondary payer after your insurance.
  5. If the discount doesn’t apply at the counter, two questions: “Did you run my insurance as primary?” and “Does my plan actually cover this drug?”

What If Your Insurance Says No? Three Paths Forward

Per Ro’s 2025 Coverage Checker Report, 43% of people who ran a check had commercial coverage for a GLP-1 for weight loss. Coverage for diabetes indications is far more common. If your plan excluded or denied your GLP-1, you have three real paths forward.

Path 1: Appeal the denial

Many prior-authorization denials can be overturned on appeal with proper documentation. An appeal packet typically needs:

  • Your denial letter (shows the exact reason code)
  • Documented BMI history from your EMR
  • Documentation of comorbidities (hypertension, hyperlipidemia, T2D, sleep apnea, cardiovascular disease)
  • Documented prior weight-loss attempts — diet and exercise programs, prior anti-obesity medication trials
  • A letter of medical necessity from your prescriber
Timeline: 1–3 weeks is typical once the appeal is submitted, longer if your plan requires a peer-to-peer review. If you’re a Ro Body member, Ro’s insurance concierge files the appeal for you as part of the membership.

Path 2: Switch to a covered drug

Your plan probably covers a GLP-1 even if it doesn’t cover your first choice. Real example from 2025: CVS Caremark stopped covering Zepbound and directed patients to Wegovy instead. Same outcome category, different drug, coverage restored, copay back to $25. Before committing to cash-pay, ask your plan: “Which GLP-1s are on my formulary?”

Path 3: Cash-pay through an FDA-approved program

If your plan flat-out excludes weight-loss GLP-1s, the cheapest FDA-approved fallbacks are:

Foundayo (oral)

$149/month starter dose through Lilly

Wegovy pill

$149/month starter doses through NovoCare Pharmacy (through Aug 31, 2026)

Wegovy pen

$199/month first two fills for new patients (through June 30, 2026), then $349/month

Zepbound KwikPen

$299–$449/month through LillyDirect

Ro offers all of these at the same prices as LillyDirect, NovoCare Pharmacy, and TrumpRx — matching manufacturer direct pricing — with the Ro Body membership added ($39 first month, $149/month ongoing, or as low as $74/month with annual prepay). Sesame Care sells branded GLP-1s across the widest formulary (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda) with Costco-member pricing on Wegovy and Ozempic.

The Prior Authorization Checklist: 11 Items That Predict Approval

Prior authorization is the single biggest blocker to getting a GLP-1 covered. This checklist reflects the criteria commonly requested by major commercial health plans and pharmacy benefit managers. Print it. Bring it to your next appointment. Hand it to your doctor’s office.

  1. 1
    Documented BMI: Most plans require BMI ≥30, or BMI ≥27 with a weight-related comorbidity.
  2. 2
    Documented comorbidity (if BMI is 27–29.9): Commonly accepted: type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, established cardiovascular disease.
  3. 3
    Recent weight history: 6+ months of documented weight in EMR records is often requested.
  4. 4
    Prior lifestyle intervention documented: Evidence of 3–6 months of a supervised diet and/or exercise program that didn't produce sustained weight loss.
  5. 5
    Prior medication trial (if step therapy applies): Some plans require trial and failure of older anti-obesity drugs before approving a GLP-1. Documentation of trial and failure or intolerance is needed.
  6. 6
    FDA-approved indication matches the diagnosis: For weight loss: Wegovy, Zepbound, Foundayo, Saxenda. For type 2 diabetes: Ozempic, Mounjaro, Rybelsus. Off-label prescribing gets denied far more often.
  7. 7
    Letter of medical necessity: From your prescribing provider. Should explain why this specific drug over a cheaper alternative.
  8. 8
    Baseline labs: A1C, lipid panel, and renal function are commonly requested.
  9. 9
    No listed contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Pancreatitis history is a common review point.
  10. 10
    Treatment plan: Dose titration schedule, follow-up cadence, and a weight-loss goal. Plans often require documented progress at reauthorization.
  11. 11
    Correct dispensing pharmacy: Some plans require fills through designated specialty pharmacies; filling elsewhere can trigger a denial.

What Changes If You Have Medicare or Medicaid?

Medicare and Medicaid beneficiaries are excluded from manufacturer savings cards by federal law — that applies even if you elect to self-pay. In 2026, two specific programs change the math.

Medicare: The GLP-1 Bridge launches July 1, 2026

Announced by CMS in December 2025 and detailed in a March 2026 FAQ, the Medicare GLP-1 Bridge is a short-term demonstration running July 1, 2026 through December 31, 2026 that lets eligible Medicare Part D beneficiaries access specific GLP-1 drugs at a $50/month copay for weight-loss indications. A CMS central processor handles prior authorization and claims — Part D plans don’t administer it.

Covered drugs for the Bridge

  • Wegovy: All formulations (injection and tablets)
  • Zepbound: KwikPen formulation ONLY — single-dose vials/pens NOT included
  • Foundayo: All formulations (added April 6, 2026)

Eligibility criteria (must meet one of three)

  • Tier 1: BMI ≥35 alone
  • Tier 2: BMI ≥30 with heart failure with preserved ejection fraction, uncontrolled hypertension on two antihypertensives, or CKD stage 3a+
  • Tier 3: BMI ≥27 with pre-diabetes (ADA guidelines), prior MI, prior stroke, or symptomatic peripheral artery disease
What happens after December 31, 2026? The Bridge ends. Continued Medicare coverage of GLP-1s for obesity starting in 2027 depends on the BALANCE Model. If your 2027 plan doesn’t participate, you may need to switch plans during Annual Enrollment.

Source: CMS Medicare GLP-1 Bridge

Medicaid: 13 states cover GLP-1s for obesity as of January 2026

Per the Kaiser Family Foundation’s January 2026 Medicaid GLP-1 tracker, 13 state Medicaid fee-for-service programs cover GLP-1 medications for obesity treatment — down from previous years as California, New Hampshire, Pennsylvania, and South Carolina ended weight-loss GLP-1 coverage effective January 1, 2026. T2D coverage under Medicaid remains widely available. For weight-loss indications, check your state’s Medicaid formulary directly — rules are changing quarterly.

The employer-plan context

Per the Peterson-KFF Health System Tracker (2025 data): only 19% of firms with 200+ workers and 43% of firms with 5,000+ workers reported covering GLP-1s for weight loss. That’s why so many commercially insured readers still land in the denial fallback scenario — “commercial insurance” isn’t a guarantee of GLP-1 coverage for weight loss.

Why We Don’t Recommend Compounded GLP-1s on This Page

This is an insurance-first query, which means we’re talking about drugs your insurance can actually pay for — and insurance only covers FDA-approved drugs.

Per the U.S. Food and Drug Administration: compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Compounded semaglutide is not interchangeable with Wegovy. Compounded tirzepatide is not interchangeable with Zepbound. Your insurance will not cover them. Your manufacturer savings card does not apply to them. The $25/month floor we’ve been discussing does not exist for compounded products.

There are legitimate reasons to consider compounded GLP-1s — primarily cost, for patients whose insurance denies coverage and who can’t afford $149–$499/month cash-pay. We cover that intent on a separate page: GLP-1 options under $200/month. But on a page titled “cheapest GLP-1 with insurance,” featuring compounded providers as winners would be dishonest — and would also fail most readers, because compounded can’t stack with insurance.

What Real Patients Say About Getting Covered

We use real, attributable quotes only. The quote below is a member testimonial from Ro’s 2025 GLP-1 Insurance Coverage Checker Report, explicitly labeled on Ro’s site as “Paid partner” — meaning the member was compensated for participating in the testimonial. We’re reproducing it because it describes the specific coverage-navigation experience our readers ask about, not as an independent endorsement or medical efficacy claim.

“I could have gone with anyone else, but Ro just spoke to me. It felt like, ‘We’re here for you.’ I initially thought I had to pay $1,000 for my medication so I sat on starting my journey for a couple of months. I decided to reach out to Ro to see if the medication cost could be lowered. Within two days, Ro ran my prior authorization and guided me to a savings card. When I went to CVS to pick up my prescription, it was just $25.”

Disclosure: Weight Loss Provider Guide has an affiliate relationship with Ro. This testimonial is a paid patient testimonial as disclosed by Ro on its own report page. Individual experiences vary. The testimonial describes coverage and service navigation experience only — it does not imply typical clinical results, weight-loss outcomes, or medical efficacy.

How We Verified This (And What We Couldn’t)

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. For this page:

  • Every price cell in the cost table was pulled from the manufacturer’s own pages or the provider’s own pricing page as of April 21, 2026.
  • Medicare GLP-1 Bridge details pulled from CMS.gov’s Medicare GLP-1 Bridge page, last CMS update April 6, 2026.
  • Medicaid state coverage data from the Kaiser Family Foundation’s January 2026 tracker.
  • Employer coverage rates from Peterson-KFF Health System Tracker (2025 data).
  • Ro Coverage Checker statistics (43% with GLP-1 coverage for weight loss; near-universal T2D coverage) from Ro’s published 2025 Coverage Checker Report covering user data from August 13, 2024 through April 17, 2025.
What we did not independently verify: Sesame Care’s live plan pricing varies across their landing pages (we observed $59/mo annual and $99/mo starting on different pages) — verify at checkout. State-specific Medicaid claims should be re-verified per state. Manufacturer savings card terms renew annually — the 2026 terms referenced here took effect January 2, 2026 for Novo Nordisk cards and expire December 31, 2026 for Lilly cards.

Who we are: Our payout from Ro is a small fraction of what other partners pay us — we lead with Ro on this page because it’s the right recommendation for commercially insured shoppers, not because it’s the most profitable one.

Frequently Asked Questions

Still Not Sure Which GLP-1 Path Is Right for You?

If the decision branches above didn’t fully resolve your situation — maybe your plan is complicated, maybe you’re between Medicare-eligible and commercial, maybe you’re weighing cash-pay against appealing a denial — we built a short quiz that routes you to the specific next step based on your exact situation.

Find your cheapest GLP-1 path in 60 seconds

Our quiz asks about your insurance type, whether you have a prescriber, and your budget priority — then outputs the specific path (and provider) that fits your situation.

Take the free Find My GLP-1 Path quiz

If you already know you want the FDA-approved brand-name insurance path and you don’t have a prescribing doctor in hand, Ro’s free coverage check is the fastest way to learn what your plan actually covers before you commit to anything:

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Advertising disclosure. Editorial standards.

Last verified against manufacturer and CMS sources: April 21, 2026. Manufacturer savings card terms renew annually; the 2026 terms referenced here expire December 31, 2026 for Lilly cards. Next scheduled full review: July 2026, or immediately when CMS issues new Medicare GLP-1 coverage guidance.

This content is for informational purposes only and is not medical advice. Talk with a licensed healthcare provider about whether a GLP-1 medication is appropriate for you, which specific drug fits your medical history, and how to manage side effects and contraindications. Individual experiences with insurance coverage and GLP-1 treatment vary.